凯姆布雷克斯(CBM)

用户48783635432019-01-03 17:29

【汇众医疗】$C$凯姆布雷克斯(CBM)$ $$阿维斯塔(AVA)$ 生物科技制药公司 Cambrex 以2.52亿美元收购 Avista 制药公司
该项收购完成后，Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造，到独立分析、微生物测验以及固态科学等多项服务，同时将Avista的4个制药站点纳入其生...查看全文

洛杉矶吴明2015-07-15 23:23

$凯姆布雷克斯(CBM)$ 今年目标价：$80。原因：高速成长、新厂房及生产线即将竣工、即将增加巨无霸客户。查看全文

如梦幻一般2015-06-22 23:35

$凯姆布雷克斯(CBM)$ 查看全文

琬麟2015-02-07 09:21

$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文

eric08712014-02-12 00:51

$凯姆布雷克斯(CBM)$ 亲你怎么了查看全文

峰雾2011-09-11 01:13

关注$凯姆布雷克斯(CBM)$，当前价$4.86。查看全文

$凯姆布雷克斯(CBM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-24 AccNo: 0000215457-19-001001 Size: 13 KB 网页链接

$凯姆布雷克斯(CBM)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-10 AccNo: 0000932471-19-001298 Size: 45 KB 网页链接

$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2019-01-08 AccNo: 0001564590-19-000395 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.01: Completion of Acquisition or Disposition of AssetsItem 2.03: Creation of a Direct Financial Obligation or an Obliga...

$凯姆布雷克斯(CBM)$ 8-K/A [Amend] - Current report Filed: 2018-11-27 AccNo: 0001564590-18-030102 Size: 3 MBItem 9.01: Financial Statements and Exhibits 网页链接

$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2018-11-20 AccNo: 0001564590-18-029869 Size: 4 MBItem 1.01: Entry into a Material Definitive AgreementItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$凯姆布雷克斯(CBM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-08 AccNo: 0001564590-18-028270 Size: 8 MB 网页链接

$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2018-11-08 AccNo: 0001193125-18-321797 Size: 233 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$凯姆布雷克斯(CBM)$ 美东时间 2018-11-08 盘前 披露财报，预期EPS 0.59 网页链接

$凯姆布雷克斯(CBM)$ 内部交易: 2018-10-23,总裁 & CEO,KLOSK STEVEN M ,卖出,20000普通股, $54.76

$凯姆布雷克斯(CBM)$ 内部交易: 2018-10-23,总裁 & CEO,KLOSK STEVEN M ,期权,20000普通股, $17.81